Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 1984862-45-4
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1R,2R)-2-[(11bS)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]thiourea features a sterically hindered thiourea core flanked by electron-deficient aryl and complex polycyclic substituents. This configuration imparts enhanced binding affinity and metabolic stability, enabling its use in targeted small-molecule screening campaigns requiring high selectivity and solubility under physiological conditions.
N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1R,2R)-2-[(11bS)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]thiourea serves as a structurally complex, bench-stable thiourea derivative enabling targeted functionalization in medicinal chemistry campaigns. Its trifluoromethylated aryl group enhances metabolic stability and lipophilicity, while the fused dinaphthazepine core provides a rigid, three-dimensional scaffold suitable for probing protein-ligand interactions. The thiourea moiety facilitates hydrogen bonding in target engagement and supports purification via crystallization or chromatography. Functions effectively in standard coupling protocols and demonstrates compatibility with diverse reaction conditions.
|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H315-H319-H335
|
|
|
Precautionary Statements : P261-P280-P302+P352
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: